Search fresh public links, source activity, and post angles for Weight Loss Drugs.
Fresh curated links around weight loss drugs are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Imagine shedding pounds like you just had gastric bypass—without the surgery. That’s the buzz around Eli Lilly’s new weight loss contender. Continue reading…
SEATTLE — Demand for weight-loss drugs is ballooning across the United States, and Amazon wants in. The Seattle-based tech giant launched its own GLP-1 program Tuesday aimed at str...
Experimental drug retatrutide cut weight by nearly 30% in Phase 3 trials, outperforming approved therapies, Eli Lilly says.
People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.
Bariatric surgery and GLP-1 medications like Wegovy and Zepbound are the two most effective ways to shed pounds.A recent JAMA study shows both methods dramatically cut body fat wit...
A large-scale analysis suggests that GLP-1 receptor agonists may do more than manage weight or blood sugar. New research suggests that GLP-1 weight loss drugs may provide lasting p...
Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker...
The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over the popular drugs.
The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over the popular drugs.
THURSDAY, April 2, 2026 — A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved through review faster than most d...
Foundayo is the first oral GLP-1 weight loss pill that doesn't require fasting.
The world of weight management is evolving faster than ever, and a new drug discovery is setting a historic milestone for obesity treatment.
An authoritative look at current FDA-approved weight loss medications, their brands and results, and how obesity intersects with disability
There is a misunderstanding that has taken hold in how people speak about the popular “weight loss” medications like Ozempic and Wegovy. They are often described as drugs that caus...
A new Sunday Independent/Ireland Thinks poll has captured the prevalence of weight-loss drugs here and the attitudes of Irish people towards the medication. Five per cent of respo...
The U.S. Food and Drug Administration on Wednesday approved Eli Lilly's weight-loss pill, making it the second to market after Novo Nordisk's oral Wegovy, as the companies fight to...
GLP-1 weight-loss drugs like Ozempic and Wegovy are often celebrated as game-changing solutions—but new research reveals a surprising social twist. People who lose weight using the...
FRIDAY, May 8, 2026 (Health Day News) — Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a notable shift for M...
The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-relate...
Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.
FRIDAY, April 17, 2026 — A new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are GLP-1s actually needed to achie...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.